This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Alberto Zambon


Current positions: Associate Professor of Medicine, Department of Medicine – University of Padua School of Medicine – Italy; Affiliate Assistant Professor, of Medicine, Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, WA, USA
MD degree in 1988, board certified in Endocrinology and Metabolism (1993), and PhD in Gerontology from the University of Padua (1998).

Post-Doctoral Fellow at the Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, (1991-1993 and 1995-1998), where he was appointed Acting Assistant Professor of Medicine (1999).

American Heart Association (AHA) Fellowship award (1996-97), the 1997 Young Faculty Award of the American Society for Clinical Investigation, the Paul Beeson Physician Faculty Scholarship of American Federation For Aging Research (1998-2001), the Merck Young Investigators on Lipid Research Award for outstanding research contribution (1999) and the Award for Outstanding Scientific Contributions (2000 and 2001) from the University of Padua, Italy.

Research interests concentrate on the pathogenesis of atherosclerosis focusing on the mechanisms of atherosclerotic plaque progression/regression, the genetic background leading to lipoprotein abnormalities and new therapeutic options modulating the atherothrombotic process.

He has authored/co-authored more than 90 peer-reviewed publications, 5 book chapters, and has delivered more than 250 invited lectures.

Professor Zambon is currently: member of the national board of the Italian Atherosclerosis Society (SISA) Foundation; member of the European Atherosclerosis Society (EAS), Gold Heart Member of the AHA and FAHA; member of the International Atherosclerosis Society (IAS). He has been part of the EMA SAG for lipid and lipoproteins related topics.

Membership Software Powered by YourMembership  ::  Legal